期刊文献+

EPO在甲状腺乳头状癌中的表达

下载PDF
导出
摘要 目的:研究EPO在甲状腺乳头状癌中的表达。方法 :收集武汉大学人民医院存档甲状腺乳头状癌蜡块40例,其中男12例,女28例,年龄23~68岁。甲状腺癌组患者术前均未做放、化疗。采用免疫组织化学方法研究EPO在甲状腺癌中的表达水平,采用HPIAS-1000图文报告管理系统对EPO的表达进行统计分析。结果:甲状腺乳头状癌组织中EPO呈高表达,癌旁组织中EPO呈低表达。图像分析结果显示,EPO在癌旁组织和甲状腺乳头状癌组织之间平均光密度及阳性面积率的差异有显著性意义(P<0.05)。结论:EPO在甲状腺乳头状癌中的高表达与肿瘤的发生密切相关。
出处 《数理医药学杂志》 2013年第1期37-38,共2页 Journal of Mathematical Medicine
  • 相关文献

参考文献16

  • 1Volante M,Papotti M. Poorly differentiated thyroid carcinoma:5years after the 2004 WHO classification of endocrine tumours[J].Endocrine Pathology,2010.1-6. 被引量:1
  • 2Westenfe7,Bongiovanni M,Sadow PM,Faquin WC. Poorly differentiated thyroid 2.carcinoma:A cytologic-histologic review[J].Advances in Anatomic Pathology,2009.283-289. 被引量:1
  • 3lder C,Baranowski R L. Erythropoietin stimulates proliferation of human renal carcinoma cells[J].Kidney International,2000.647-657. 被引量:1
  • 4McBroom J W,Acs G,Rose G S. Erythropoeitin receptor function and expression in epithelial ovarian carcinoma[J].Gynecologic Oncology,2005,(03):571-577.doi:10.1016/j.ygyno.2005.06.038. 被引量:1
  • 5Sanders EM Jr,LiVolsi VA,Brierley J,Shin J,Randolph GW. An evidence-based review of poorly differentiated thyroid cancer[J].World Journal of Surgery,2007.934-945. 被引量:1
  • 6Erkilic S,Kocer NE. Insular carcinoma of the thyroid with uncommon cytologic features:Anisokaryotic cells and microfollicles containing dense colloid[J].Pathology Research and Practice,2006.389-393. 被引量:1
  • 7Jogai S,Jassar A,Adisena A. Fine needle aspiration cytology of thyroid lesions[J].Acta Cytologica,2005.483-488. 被引量:1
  • 8Acs G,Zhang P J,Rebbeck T R. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma[J].Cancer,2002.969-981. 被引量:1
  • 9Henke M,Laszig R,Rube C. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:randomised,doubleblind,placebo2 controlled trial[J].The Lancet,2003.1255-1260. 被引量:1
  • 10Leyland2Jones B,Semiglazov V,Pawlicki M. Maintaining normal hemoglobin levels with epoetin a in mainly nonanemic patients with metastatic breast cancer receiving first2line chemotherapy:a survival study[J].Journal of Clinical Oncology,2005.5960-5972. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部